During its Spring Symposium this year, the European Academy of Dermatology and Venerology (EADV) brought stakeholders together to evaluate the effectiveness of the European Commission’s Beating Cancer Plan.
The plan identifies key recommendations from stakeholders which increase measures on preventing skin cancer and melanoma. The Policy Roundtable Discussion – ‘Beating Cancer: how to step-up EU efforts of skin cancer prevention’ – engages with policy makers and stakeholders to support a patient approach to advocacy around skin cancer prevention, whilst creating a bridge between scientific research and the EU health policy agenda, explains the EADV.
The four key action areas discussed in the plan were prevention of cancer by addressing key risk factors such as tobacco, harmful alcohol consumption and environmental pollution; recognising early the detection of cancerous cells by improving access, quality, and diagnostics to ensure that 90% of the EU population who qualify for breast, cervical and colorectal cancer screenings are often this by 2025; and access to diagnosis and treatment to ensure better integrated and comprehensive cancer care and to improve the quality of life for cancer patients and survivors, which include rehabilitation, potential tumour recurrence and measures to support re-integration in the workplace.
The discussion is the first in a series of Policy Roundtable Discussions by EADV moderated by EADV president Professor Alexander Stratigos.
Following the Roundtable, the Academy will continue to play its part through engaging in comprehensive discussions with EU policymakers and health stakeholders to improve and advance skin cancer care across the EU, stated the EADV. The group will meet regularly to discuss and review the implementation of the Cancer Plan at least twice a year to work more consistently and make ownership of Europe’s Beating Cancer Plan fully inclusive.
Professor Stratigos commented, “The EU Beating Cancer Plan recognises the burden of cancer as a key societal challenge requiring additional research. EADV believes that the research into prevention, early diagnosis, treatment, and follow-up care of skin cancers is urgently needed. We are strongly committed to working with key stakeholders to firmly position the problem within the EU health agenda and bring to the forefront important issues around our speciality.”
The Beating Cancer Plan will be reviewed by the end of 2024 and will assess whether the action taken is sufficient to achieve the objectives, or whether additional measures are necessary.